91360 MedTech nets tens of millions of yuan in financing

91360 MedTech recently announced the completion of a new round of financing, raising tens of millions of yuan.

91360 MedTech recently announced the completion of a new round of financing, raising tens of millions of yuan.

The round was led by Qianzhao Fund, a fund focused on the pathology industry whose affiliated funds have completed investments of nearly two billion yuan in the IVD field in recent years.

Proceeds from the latest round of funding will be mainly used for product development, product chain optimization and upgrading, and deep mining of the value of data.

Previously, 91360 MedTech has garnered tens of millions of yuan in investments from Wali Investment, Huituo Investment and BC Capital.

91360 MedTech was founded in 2012. Currently, the company has evolved from a digital pathology teleconsultation platform to a comprehensive service provider that provides digital pathology information solutions for the industry with “Digital Pathology + AI” as the core.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/07/03/91360-medtech-nets-tens-of-millions-of-yuan-in-financing/.

Leave a Reply

Please Login to Comment